Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
about
Interleukin-6: an emerging regulator of pathological painPharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.An effective medical partnership in Nagasaki, Japan for patients with rheumatoid arthritis.Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis.
P2860
Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cost-effectiveness of tocilizu ...... RA observational cohort study.
@ast
Cost-effectiveness of tocilizu ...... RA observational cohort study.
@en
type
label
Cost-effectiveness of tocilizu ...... RA observational cohort study.
@ast
Cost-effectiveness of tocilizu ...... RA observational cohort study.
@en
prefLabel
Cost-effectiveness of tocilizu ...... RA observational cohort study.
@ast
Cost-effectiveness of tocilizu ...... RA observational cohort study.
@en
P2093
P2860
P1433
P1476
Cost-effectiveness of tocilizu ...... RA observational cohort study.
@en
P2093
Akiko Kobayashi
Atsuo Taniguchi
Ayako Nakajima
Daisuke Hoshi
Eiichi Tanaka
Eisuke Inoue
Hisashi Yamanaka
Kumi Shidara
Naoki Sugimoto
P2860
P304
P356
10.3109/14397595.2014.1001475
P577
2015-02-11T00:00:00Z